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Abslract
Oral squamous cell carcinorna ( OSCC ) is the most common malignanr tumor ofthe oral cavity, and ils
account for 80-90% ofall malignancies in oral cavity. The aim of this study was to detemine the pr€sence
of p53 muiations and to associate these mutations with the histopathological type of OSCC such as w€ll
differentiated and poorly differentiated. Analitycal observational comparative study by cross sectional design
was used. Forty untreated well and poorly difleren.iated OSCC biopsy sample and normal rissue biopsy
material taken fiom 16 normal patients were analyz€d for the presence ofmutation in the cons€rved region of
the p53 gene €specially in exon 5 by polymerase chain reaction-single strand conformation polymorphism
(PCR-SSCP). The results of this study showed thar p53 gene mutarions were detected in exon 5i ll/40
(27,5%) with heterozygous mutation 9/ll (81,8%). The incidence in exon 5 ofp53 gene mutarion was
significantly accociated with well differentiated 2/20 (l0o/o\ and poorly diferentiated 9/20 (45%)
OSCC(P=0,013). This study concludes that l) mutation in exon 5 of p5l gene occuned ftequ€ntly in OSCC;
2) exon 5 of the p53 gene could b€ one of the fte specific targets for histopathological grade of OSCC;
l)mutation in exon 5 ofp53 gene could be important prognosric factor in OSCC. Indonesian Journat of
Dentistn 2006: Edisi Khu:us KPPIKG Xly:239-242
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Introduction
Oral squamous cell carcinona ( OSCC ) $ the
most common malignant umor of the oral cavjty,
and its account for 80-90% ofall malignancies in
oral cavity. Mortality rat€ remains high is about 5%
in worldwide and 2,4yo-3,Sin/o in Indonesia of all
cancers death.r'  Until now, th€ molecular
pathogenesis ofOSCC is still unclear and caused by
the diagnosis is only based on clinicopathological
examination. Consequ€ntly, the most fr€quent
OSCC cases are found in advanced stage
approximately 76,3 % ther€for€ th€ management of
OSCC has not shown satisfactory outcome.2
Disruplion of the €ell cycl€ as well as
regulatory genes compooent which involv€d in
controling c€ll cycl€ is the main factor in the
development process ofall malignancies. p5l tumor
suppressor gene has an jmportant role in malignancy
development process especially in early phase ofcell
cycle Gl-S and loss of function p53 gene is the
mosl common cause of OSCC.- Funhermore. p51
g€ne has been shown a direct activation and an
essential rol€ to control and to r€gulate cell cycle as
well as could induce apoprosis.a Subsequently,
inactivation of p53 gene would be the activity of
p53 disrupted results in uncontrolled cel
prolif€ration and if continuously occur therefore
could be malignancy in all €ancers. a
Although the tumor suppressor gen€ p53 h rhe
most fiequently mutated gene in a wide variety of
human cancers, it is noi clear whether the p53 gene
is also involved in OSCC since few studies have
been reported previoudy on p53 muration in OSCC
and . the rol€ of p5J muulion in the eliolog} ofoml
cancer has nol baen rigorously studi€d in lndonesia
Previous studies hav€ shown a lower incidence of
mutation of pJJ gene associated with sell
Jifferentiation iquamous cell carcinoma in Japan 
'
How€ver, these studies have been based on an
anatvsis of r€latively few cases of oral squamous
cell carcinoma5 (oSCcl ln addition. association
beMeen th€ obsened pan€m or incidence of pJJ
muBtions in OSCC wnh associated
histopathological grade were not explored in
s mbava. lndonesia. ln this sody' w€ examrned
nrmor iissues from 40 patients wilh primary OSCC
for mutations in one of the cons€rved rcgions of th€
o53 eene (exon 5) and analyzed lhe incidence of
mutaiions for asso{iation with histopaLhological
grade
Th€ aim of this study \{as to determm€ the
Dresence of p53 mutations and to assocnte th€se
mutations wiih the histopathological typ€ of OSCC
such as well differentiated and poorly differentiated'
Materials snd Methods
Patients, tissue specim€fls and clinicopatho-
loeical diaqnosis. The Elhical Clearance Comminee
.i U.ai.ut Facul$, Airlangga University. Dr
Suromo General Hospital Surabaya, aPproved this
exDerimental study. In this sody, analitycal
observational comparative study by cross sectional
desisn was used. The material of observation ln ths
sodt were 40 untreated Patients who clinical
diagnosis as susPecled oral cancer and
histopathological diagnosis irom bropsy Irssue
sD€cimens were reconfirmed from hemato\ylIn
eosin stained sections wer€ 20 well differ€ntiation
oSCc and 20 poorlv differentiation Oscc
accordine to the wHO cl.ssification and 16 normal
Datients ;ho fulfilled the observational requirement'
ihe lumor staging (TNM) was determined according
to the 198? classification ofUICC.
For each cas€. a pair of tumor samPle and
normal or controlled sample were surgically
dissected into small pieces, frozen immediately in
liquid nitrogen and stor€d at _ 80'C Fuihermore,
Datients were classified into two grouPs consisled of
40 tumor samples were 20 well differentiated
OSCC,20 poorly dilferentiated OSCC and 16
normal or cootrolled sample patients who laken from
normal tissue on imPacted thitd molar with surg€ry
indication.
DNA Extraction.
The DNA was extract€d from all tumor and
control samples. Th€y were then cut inlo small
Dieces (0,5 x 0,5 x 0,5cin ) and placed into
eppendorf tub€s, *ashed with PBS solution, added
with ?00t of 50 nM Tris HCl, PH 8, 100 mM
EDTA, 100 nM NaCl, l% SDS,50 pl of lG-20
mg/ml prot€inase-K and incubat€d at 55'C
ov€rnight. DNA extraction in 0,5 nl fenol / CIAA
and placed on olerhead .haker ( fppendorf  mi\er
5432) tot 2 hourt. spin eppendorf for 5 min.
shaking on vertical rotator and transfer to a fiesh
tube. Theq added with 500[l isoproPanol / etanol
and mix until stringy precipitate forn, decant
suDematan. Followed by added 500}1! TE bufTer and
in;ubated ovemight at room temperature. Afterward'
eppendorftube was shaken with hand in order to be
w;ll mixed. DNA identification was done using 2%
agarose gel electroforesis and visualiz€d by UV
lighL. DNA - concentration tesl using
spectrophotometry."
PCR-SSCP Analysis.
PCR "as performed in 25 ul of reaction
mixture containing 100 150 ng of g€nomic DNA,
PCR bead / PCR Ready to go, 2! DNA sample
OSCC, lFl primerl exon 5,4, lpl primer 2 exon 5A'
2l ! dHro in ePpendorf tube and shaking on
vertical rotator (Perkin-Elmer Cetus, Norwalk, CT)
We used 2 pairs ofprimen s€t to amPliry as follows:
exon 5A, J'_TGT TCA CTT GTG CCC TGA
C T  3 ' a n d 5 ' - A G C  A A T  C A G  T G A  G G A
ATC AG 3' for exon 58; 5'- TTC AAC TCT
GTC TCC TTC CT 3'and s'-CAG CCC
T G T  C C T  C I C  I C C  A G - 3  T h e  P C R  f o r
DNA normal sampels are equally Fosedure as
performed by t?ical PCR condition . Twical PCR
conditions were as follows:4 min of denaturation at
94"C, then 30 cycles at 95'C for 4 min, amealing at
55'C for 2 nin, and ext€nsion 72'C for 3 min. An
elongation step at 72"C for 2 min was added to the
final cycle for €xons for DNA tumor PcR
condilions for p53 exon 5A continued as follows: I
min ofdenatumtion al 94"C, then 30 cycl€s at 94'C
for I min,56"c for I min, and 72'C for 2 min An
eloogation step at ?2'C for 5 min was added to the
final cycle for exons A The optimum PCR product
has shown wilh I band in 2% agarose gel
electroforesis. Then , 5 }ll exon 5A PCR product
used by template for p53 exon 58 with added I !l
primer I exon 58, lpl primer 2 exon 58, PCR ,ead
/ PCk Ready to go, 18 ! dHr0. PCR conditions for
exon 58 as follows: denaturation 95'C for 4 min.
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aDnealing 6l'C for 2 min. Extension 72'C for 3 mrn.
I crcle. Then. denaturation 9.1"C for I lnrn.
annealing 62'C for I rnin, exlension 72oC fbr 2 min,
l0 clcles and exta extension 72"C tbr 5 min. Ihe
optrmum of PCR product has sho\+ti with I band in
:q. agarosc gel electrophorcsis compared with htnd
0f iNA marker at 300 bp.'
For SSCP Analysis. 5 pl aliquots of the
lal)cled PCR produch werc mixed with l0 pl of
tilniamide loading dye (95% fonnamide,20 mM
ED IA. 0.05% bromphenol blue. and 0.05% xylene
clat]ol) and were denatured for l0 nin at 95'C and
chi l l fd on ice unt i l  loading for 5-10 min. A 15-pl
aiqu.r of each sample was loaded onto a 12%
pollacrylamide gel with or without containing 5%
gllcefol an{i eleclrophoresis was performed at 1500c
consratlt volume for 5h at room tempemture.
l , ' r n ' . o  b )  . i l t c r  n a i n i n . j  $ i t h  r h e  l b l l o w i n g
procedure: lixer solution (7,5% acetic acid) for:10
min and $ashed (3x) using dionized waier (dHr0)
for 5 min. Then added with 100 ml silver nitrate
solurion ( 1.5 gil AgNor,0.056% formaldehyd€) for
.15 min and rinsed rith dionized water tbr 15
seconds. Furthermore. image developmenl was done
{iih developer solutjon (30 gil- Na,COr, 0,0056
fonnaldehyde. 2me/l sodium thiosxlfate) for 2-5 mrn
nd stop solulion with fixer solulion (7,5% acetic
acid. used at 4"C ) for 5 min."
Stat is l icr lAnalysis.
All slaiistical analyses lvere perlbrmed using
SPSS program version I t. The Contigencv
coefllcienr lest were used for statistical analysis of
Lheassocialion betweenlhe incidence of p53 exon 5
and hisropathogical grade such as. well
differentiation and poofl! diferentiation.
Results
Singlc-siranded conformation poly or?hrsm
(SSCP) anaiysis was used to analyze all tumor and
conlrol samples for mrtaiions within exon 5 of the
pij gene, which is one of thc regions nost
liequcntly affecied by mutations in human tumon.
Cases displaying an allered electrophoretic mobiliry
were re"amplified in another sepamte reaction
Eleven of ihe ,10 tumors (27,5%) exfiibited 2
bands (homozygote ) or extra bands ( i or 4 band;
hcr(rol l !or(  ,  in rhc SsCP andh ' i r  of  p5l  e\on 5 in
unsimilar position with 2 band of DNA conaol,
indicaling mutations ( + ; or scor€ l). Twenty nine of
40 tumors (72,5 %) of p53 exon 5 show€d 2 band
uitfi similar posirion to 2 band of DNA controlled
indicating absence of mutation ( - ; or score 0 ).
Two of ll ( 18.2 %) of p53 exon 5 showed
honozlgote muialion and heterozygote mutatron
9/l I (81,%). Tabel I.Fig L
Table L lncidence nutations of lhe pjj ecDe exon 5
Figure l. P(]R-SSCP dalyis oflhcp5l go. eron 5 bysnver
. r " rn .ng .  loL  hdd t r i r f  . f iRed mob i l iF  na  seen in
rumvr  \u  r l  rJ r r  n ' .hosenhereo4ut<nr td ion
lnd homozygole nuaioo vd sNn intumorNo16 -
L a n e s N o : 1 l  i 2  3 l  i 4  i 5  1 6  3 7  l 8  1 9  4 0  N
vru (!3/
Noles : N = l)NA conlrol
lhe incidenc€ of p53 exon 5 (27,5%) was
significantly associated with well diftbrentiated and
poorly differentiatedpatients (p:0,013). Tabel 2.
Tabel 2. the result of slatisrical lest oflhe Asocia$on
be$ccn incjdence of p53 exon 5 and
hisropathotoeical f.aturc (well dilTcrentiation
ard poorl) ditircntiation) oi OSCC.
Nors : well diff = well difilrentiation. poodr" dilF poorly
Discussion
Mutalion at pJJ has been demonstrated in over
50% of all hunan cancers. Th€ much higher
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mulation tr€quenc) ofp53 exon 5 ofOSCC deted€d
i'" s'ii-t" io ";r 7 i0) " while different liom the
find'ns. of m) research since lhe sa e screenrng
brotoc'ol wasable lo delecl frequenl p5r flutat'ons ln
iJ.r n"at -a location tumor samPles Therefore
:#; 
''il; 
t"'. been based on an anabsis of
iii"tr-"it- r." cases of oml squamous 'ell
.'",.;ii'iut losccr' ln addirion associarions
bel\^een lhe incidence of psl mulatrons exon r rn
'* "."....a region especiall) e{on 5 wilh
f,i',"0",t'"i"gi."t izde such wetl diffetenliared and
1"".i"'iir"?.*l,i.a oscc wer€ not e\plored in"r,la"ori..i" rn rrtit "uav.Inuration i  p5l-exon 5 has
,i"", lr ,s oo rl ia0, which differ€ r iom
rn""ii-i. r".a.*. "r p5J exon 5 in Sri bnt'a 
-
'irt*" 
at**p*.1"t may be panly a resuh nf lhe
inclu\ion ofpalienls fiom differenl geographc areas
and differences in the technique us€d to analyTe Ine
mutat ions. ?' ' ' ' -aG.". .  
of  mulal ion p5J exon 5 was found
lZ.y" rolOf l r  is speculated $al other genetL
alterarions uhich may be either equivalenl lo
;""."""ii"" "rth. ""rni"t tunction ofrhe P53 nrotein
or involved in other carcinogenic pathways or may
-"u..a Ur rt'e proOu.t ofthe MDM2 gene is tnown
ro bind io p5J Protein and inhibil rls.abrlrt) Io
".,'""i. n"'it.ripii"n causing loss ot the-normal
il'i""" "i,r'. r:l gene Alternatitelv The F6
"lii.'"|"] Hpv rvp*-tu and l8 are considered ro
i^".  n*. ' "- i " i  ,u ' t i t )  bv binding to rhe psj
"r""i" "na i"hlui,ing its tunction lhrough a
itlq"iii"-J.p*a*t p,ol.ol).sis \)srem could be losc
of function of the P5l gene 
"
lntereslingl). high muration of helerozlgote
g t .S"" i  q r  r  I  iSl . 'on S can al :o caused al lel ic los'r
of D5J and dbnornally amplified cenlrosomes $aI
oroiornaft rrf"., mrtotic fldel'r) and resulled in
in.quut ..gt.gorion of chromo\ornes and enhanced
senetic instabilitY.
Th€ dssosianon betw€en incidence murallon
.r "si i;;; 5, wirh welt and poorlv drfferenriat€d
osLi *et.  stur ist icat5 signi f icant(P-0011' Th€se
i"ai"*' i"gg.u.c ,t'"i,t'eie is a req high degree ot
"." .r i i ; " .Ll ; r io In these tumors and lhe p51 eron
i-".^. i' " p'i'1ry rargered of OSCC and plaved a
.,iii"r i.l. "r tnit tu-mor suppre'sor gene in the
,nrtrirr"p .ar.inog.netit process for OSCC Hence
'i .un uJ -*rraia ,n"r turalion in €xon 5 of P5l
eene occuffed fiequ€ntly in OSCC and could b€ one
iiit'e ttre .pe.iii. largeted on hrslopalhological
srade of oSCC as $ell a\ ma) could b€ imponant
irognostic factor in oSCC.o
l u .
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